COPD News & Updates
- Brinsupri: First Once-Daily Tablet for Non-Cystic Fibrosis Bronchiectasis
August 13, 2025 — Brinsupri (brensocatib) is a new oral medicine approved to treat a long-term lung disease known as non-cystic fibrosis bronchiectasis (NCFB) in adults and children ages 12 or older.
- FDA OKs Nucala for Hard-to-Treat COPD
May 23, 2025 — The FDA has approved the asthma drug Nucala for adults with chronic obstructive pulmonary disease (COPD).
- Dupixent Gets FDA Approval for COPD
October 2, 2024 — The label expansion provides a new option for the hundreds of thousands of Americans with inadequately controlled COPD.
